NEMBUTAL WIE VIEL - AN OVERVIEW

Monoamine oxidase inhibitors (MAOI) may perhaps inhibit barbiturate metabolism and lengthen barbiturate outcomes; watch carefullypentobarbital will lower the extent or impact of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. For patients receiving exemestane that has a potent CYP3A4 inducer the advised dose